• Pharma’s next edge won’t come from the biggest model, but the boldest instincts. Learn how to spot moments of asymmetric opportunity - when to trust data, and when to break pattern. You’ll leave knowing how AI  with  timing is your new competitive advantage.

‍

• Explore how AI tools can humanise science for experts, prescribers, and patients alike.
• Discover what happens when scientific data meets behavioural design.

• Hear how unified knowledge, AI-supported insight discovery and cross-pharma collaboration, ( field engagement, field insights, benchmarking) can elevate planning, precision and strategic impact. 
• Learn how connected medical and commercial teams can unlock earlier signals, generate higher-quality evidence, measure what matters and enable truly intelligent commercialisation through the Medical Affairs lens. 
• Exclusive insights on how Inizio are redefining intelligent decision-making across Medical Affairs and adjacent commercial functions.

• The EU’s AI Act will reshape how pharma markets, personalises, and measures. This panel explore pharma frameworks, and how to stay compliant without holding back innovation.

Outcome: Leave a strong understanding of how AI solutions may violate the EU AI Act. Critical for those tasked with rolling out global initiatives in EU markets.

• See how Tangram has built a multi-agentic AI ecosystem to discover and prioritise drug targets for its GalOmic therapeutic pipeline.
• Watch a live demo of AI-driven gene-disease pair discovery (it’s amazing!)
• Understand how GenAI co-scientists can connect and reason on diverse and multi-layered data.

Outcome: Understand how a commercially and scientifically aligned AI platform can scale drug discovery, today.

• Explore how a set of Medical Affairs copilot agents or custom GPTs can transform everyday work.
• From product expert agents that deliver instant answers derived from approved FAQs, publications and labels to congress insight and reporting agents helping teams capture, and synthesise insights into high-quality outputs.
• Hear what guardrails should be in place from day one, so these agents reduce risk rather than headaches

Outcome: Leave with a clear, achievable blueprint for an agent-ready Medical Affairs model that you can plug into your existing workflows to free up your teams for what matters the most.

‍

• As agents reshape content discovery, your future campaigns must become agent-readable.
• Develop an internal content production roadmap that is designed for future AI acceptance.
• How to get found when search becomes a conversation. And how to create engagement when your audience expects personalized answers, instantly.

Outcome: Leave with an “Agent-Readiness” checklist for your next marketing or communication campaign!

‍

• What’s breaking and what’s worth protecting: why “hours + assets” is collapsing under in-house AI, consolidation and procurement logic, and how to avoid the race-to-the-bottom trap.
• Inside the client firewall: how secure LLMs/copilots are already reshaping asset ownership, accountability and risk and where agencies still earn their keep as a governance + quality creators.
• Hear where value is moving next: from making stuff to designing the system, hear how clear swimlanes, shared guardrails, and an outcomes-first collaboration model can lead to improved HCP/patient impact - not just increased throughput.

Outcome: Leave with a practical proposal for redrawn client-agency swimlanes, with a clear view on what to strip out and what to protect.

• Discover what happens when an AI personalization campaign crashes into regulatory review and the lessons that came out of it.
• Learn who are the critical AI ambassadors that can help you combine speed, creative excellence, sign-off, and scientific rigour.
• The critical questions to ask your colleagues before you embark on a complex AI driven project.

Outcome: Learn how to build AI-powered content workflows that move at marketing speed without tripping regulatory wires.

_{Disclaimer: No confidential or proprietary information from any specific company will be disclosed.}

‍

• Hear what actually has to change in people, governance, data/tech stack, and ways of working so AI becomes “how we do campaigns” and not “that cool test we once ran.”
• How to bake in compliance, medical/legal, auditability and ownership so your new innovation doesn't get stuck at the first global rollout.

Outcome: leave with a kill/park/scale checklist to separate AI that boosts outcomes from AI that just boosts activity.

‍

• In a world where AI accelerates change faster than teams can process it, discipline is your competitive advantage.
• Learn how to stay focused, energised, and adaptable when the ground keeps shifting. 
• Hear from an ex-special forces & tier-1 performance coach on how to make discipline your operating system, and not just a feeling.  

‍Outcome: Leave with a practical framework to lead yourself and your team with clarity, control, and confidence.

‍

• AI is rewriting what motivates teams. Learn to build cultures of trust, autonomy, and competence when algorithms join the team. 
• Use inclusive leadership models to maintain belonging, creativity, and resilience.

‍

• Leading generative AI experts from film, music & art reveal how their industries are transforming in this AI led world.
• See what great looks like in other verticals, and apply their lessons to your future campaign.

‍Outcome: Your annual fill of inspiration & new ideas! 

‍

• Pharma leaders share the lessons and commercial goals on AI transformation in 2026 and beyond in this interactive closing session.

‍